Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability

por Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonatė, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas
Publicado 2015

Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia

por Pileckyte, Regina, Valceckiene, Vilma, Stoskus, Mindaugas, Matuzeviciene, Reda, Sejoniene, Jurgita, Zvirblis, Tadas, Griskevicius, Laimonas
Publicado 2019

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia

por Vitkevičienė, Aida, Skiauterytė, Giedrė, Žučenka, Andrius, Stoškus, Mindaugas, Gineikienė, Eglė, Borutinskaitė, Veronika, Griškevičius, Laimonas, Navakauskienė, Rūta
Publicado 2019

Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”

por Vitkevičienė, Aida, Skiauterytė, Giedrė, Žučenka, Andrius, Stoškus, Mindaugas, Gineikienė, Eglė, Borutinskaitė, Veronika, Griškevičius, Laimonas, Navakauskienė, Rūta
Publicado 2020

Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission

por Borutinskaitė, Veronika, Žučenka, Andrius, Vitkevičienė, Aida, Stoškus, Mindaugas, Kaupinis, Algirdas, Valius, Mindaugas, Gineikienė, Eglė, Navakauskienė, Rūta
Publicado 2022

Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed...

por Norvilas, Rimvydas, Dirse, Vaidas, Semaskeviciene, Ruta, Mickeviciute, Orinta, Gineikiene, Egle, Stoskus, Mindaugas, Vaitkeviciene, Goda, Rascon, Jelena, Griskevicius, Laimonas
Publicado 2021